Skip to content

Comparative study between clinical outcomes of platelet-rich plasma and adipose stem cells in knee osteoarthritis

Comparative study between clinical outcomes of platelet-rich plasma and adipose stem cells in knee osteoarthritis

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
PACTR
Registry ID
PACTR202503493655424
Enrollment
60
Registered
2025-03-19
Start date
2025-03-11
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Orthopaedics

Interventions

Platelet Rich plasma

Sponsors

Mohamed IV University Hospital
Lead Sponsor
Regenerative medicine centre
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - Age from 18 to 75 Male or female - Bilateral symptomatic osteoarthritis of the knee (1-4 according to Kellgren-Lawrence) - Failure of non-surgical treatment for at least 3 months - Acceptance of the protocol by signing the informed consent form provided to the patient - Ability to attend all follow-up appointments

Exclusion criteria

Exclusion criteria: - Active rheumatic disease - Presence of local or general infection - Unilateral gonarthrosis - Pregnancy - Congenital or acquired diseases causing significant knee deformities - Injection of steroids or viscosupplementation in the last 3 months. - Presence of disorders that may affect the results of the operation: anaemia, thrombocytopenia, coagulation disorders, etc. - Malignant tumour - Metabolic or thyroid disorders - Recent traumatic event of the lower limb (6 months) - Surgery on the target knee in the past year - Cognitive impairment

Design outcomes

Primary

MeasureTime frame
To compare the efficacy of adipose tissue-derived MSCs and PRP in the treatment of Knee osteoarthritis, in order to guide the selection of the most effective therapy for improved management of this condition.

Secondary

MeasureTime frame
- To assess the effectiveness of PRP injections and adipose tissue in relieving or reducing pain, based on VAS, WOMAC, KOOS and SF-36 measurements. - To assess the improvement in joint mobility and the reduction in patellar shock in patients with Knee osteoarthritis by comparing the impact of the two therapies. - To analyse the impact of certain factors such as age, sex, osteoarthritis severity and the use of certain drugs on the effectiveness of PRP and adipose MSC injections in patients suffering from gonarthrosis. - To study the influence of osteoarthritis severity on the therapeutic results of PRP and adipose MSC injections. - To analyse the durability of the short- and long-term benefits of adipose MSC injections compared with PRP injections for the treatment of gonarthrosis.

Countries

Morocco

Contacts

Public ContactSiham DKHISSI

PhD student at the clinical and epidemiological research laboratory for osteoarticular pathology

s.dkhissi.ced@uca.ac.ma0665404705

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026